全文获取类型
收费全文 | 79651篇 |
免费 | 44975篇 |
国内免费 | 79篇 |
专业分类
耳鼻咽喉 | 1598篇 |
儿科学 | 4416篇 |
妇产科学 | 853篇 |
基础医学 | 15917篇 |
口腔科学 | 5273篇 |
临床医学 | 12818篇 |
内科学 | 24252篇 |
皮肤病学 | 7571篇 |
神经病学 | 13438篇 |
特种医学 | 2416篇 |
外国民族医学 | 1篇 |
外科学 | 14789篇 |
综合类 | 293篇 |
一般理论 | 29篇 |
预防医学 | 4668篇 |
眼科学 | 1545篇 |
药学 | 6263篇 |
中国医学 | 1128篇 |
肿瘤学 | 7437篇 |
出版年
2023年 | 132篇 |
2022年 | 120篇 |
2021年 | 1571篇 |
2020年 | 5305篇 |
2019年 | 11115篇 |
2018年 | 10429篇 |
2017年 | 11669篇 |
2016年 | 12318篇 |
2015年 | 12131篇 |
2014年 | 12152篇 |
2013年 | 12709篇 |
2012年 | 4667篇 |
2011年 | 4601篇 |
2010年 | 9230篇 |
2009年 | 5511篇 |
2008年 | 2436篇 |
2007年 | 1288篇 |
2006年 | 1229篇 |
2005年 | 989篇 |
2004年 | 943篇 |
2003年 | 788篇 |
2002年 | 802篇 |
2001年 | 652篇 |
2000年 | 480篇 |
1999年 | 162篇 |
1998年 | 74篇 |
1997年 | 50篇 |
1996年 | 54篇 |
1995年 | 57篇 |
1994年 | 63篇 |
1993年 | 39篇 |
1992年 | 83篇 |
1991年 | 71篇 |
1990年 | 81篇 |
1989年 | 66篇 |
1988年 | 65篇 |
1987年 | 65篇 |
1986年 | 68篇 |
1985年 | 49篇 |
1984年 | 43篇 |
1983年 | 25篇 |
1982年 | 25篇 |
1980年 | 27篇 |
1979年 | 31篇 |
1977年 | 28篇 |
1976年 | 23篇 |
1974年 | 15篇 |
1973年 | 19篇 |
1970年 | 19篇 |
1969年 | 15篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
22.
23.
Kerstin Protz Joachim Dissemond Myriam Seifert Marianne Hintner Barbara Temme Ida Verheyen‐Cronau Matthias Augustin Marina Otten 《International wound journal》2019,16(6):1252-1262
Brochures are a useful supplement to patient education. There is increasing evidence that they are an effective medium to support patient satisfaction, adherence, and empowerment. This study aims to produce reliable data on how much patients with venous leg ulcer (VLU) may profit from a brochure that focuses on VLU and on measures and aims of the related compression therapy. The evaluation took part from October 2018 until March 2019 and included 136 patients with VLU and related compression therapy. They were randomly sorted into a case group and a control group of 68 patients each. The case group received a brochure about venous disease and compression therapy and filled in a questionnaire after reading. The questions ranged from basic knowledge about VLU and compression therapy to aspects of self‐care. The control group answered the same questions without previous reading of the brochure. The results show that in almost every aspect, the patients in the case group were better informed about their diseases, the compression therapy, and how they may support the measures adequately. This study suggests that patients with VLU may profit from a brochure that explains their disease and the related compression therapy. Better knowledge and understanding may strengthen their empowerment and adherence. 相似文献
24.
25.
Achim Rosemann Adam Balen Brigitte Nerlich Christine Hauskeller Margaret Sleeboom‐Faulkner Sarah Hartley Xinqing Zhang Nick Lee 《The Hastings Center report》2019,49(3):30-42
A central problem for the international governance of heritable germline gene editing is that there are important differences in attitudes and values as well as ethical and health care considerations around the world. These differences are reflected in a complicated and diverse regulatory landscape. Several publications have discussed whether reproductive uses would be legally permissible in individual countries and whether clinical applications could emerge in the context of regulatory gaps and gray areas. Systematic comparative studies that explore issues related to the governance of this technology from different national and international perspectives are needed to address the lack of knowledge in this area. In this research report, we contribute to filling this gap by presenting views of stakeholders in the United Kingdom on challenges to the governance of heritable genome editing. We present findings from a multistakeholder study conducted in the United Kingdom between October 2016 and January 2018 and funded by the Wellcome Trust. This research included interviews, literature analysis, and a workshop. We involved leading U.K. scientists, in vitro fertilization clinicians, and representatives from regulatory bodies, patient organizations, and other civil societal organizations, as well as fertility companies. Part one of this article explores stakeholder perceptions of possible global developments in heritable genome editing and associated risks and governance challenges. Part two presents a range of policy options that were generated during the workshop in relation to the challenges discussed in part one. 相似文献
26.
27.
28.
29.
30.